FSSAI Issues Draft To Include Natamycin As Preservative In Additives Norms

New Delhi: The FSSAI has issued a draft to amend the Food Safety and Standards (Food Products Standards and Food Additives) Amendment Regulations, to include Natamycin as preservative for food products including fermented milks (plain) not heat treated after fermentation and dairy based desserts.

For both product category, Natamycin can be used with a max limit of 5mg/kg.

According to Ashwin Bhadri, CEO Equinox Labs, Natamycin is a natural antifungal agent produced by the bacterium Streptomyces natalensis. It is commonly used as a food preservative to prevent the growth of mould and yeast in products like cheese, yogurt and dried meats.

“It is generally recognised as safe and is approved for use in many countries. Natamycin is effective at very low concentrations and does not affect the taste, appearance or smell of food, making it a safe and widely accepted preservative,” said Bhadri.

FSSAI, meanwhile, has invited suggestions on the subject and stakeholders can submit their comments to the food authority.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’